Thomas Schnitzer

9PUBLICATIONS
24CO-AUTHORS
PainHaematological tumoursOphthalmologyCancer therapy (excl. chemotherapy and radiation therapy)Pharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 26, 2026
Effects of pentosan polysulfate sodium on synovial fluid biomarkers in moderate to severe knee osteoarthritis: an exploratory, phase 2, randomized, double-blind, placebo-controlled trial.

Donna L Skerrett, Catherine J M Stapledon, Mukesh Ahuja

|Apr 22, 2024
Effect size varies based on calculation method and may affect interpretation of treatment effect: an illustration using randomised clinical trials in osteoarthritis.

Thomas J Schnitzer, Philip G Conaghan, Francis Berenbaum

|Jan 21, 2023
Opioid Prescribing for Osteoarthritis: Cross-Sectional Survey among Primary Care Physicians, Rheumatologists, and Orthopaedic Surgeons.

Thomas J Schnitzer, Rebecca L Robinson, Lars Viktrup

|Mar 02, 2022
WOMAC Meaningful Within-patient Change: Results From 3 Studies of Tanezumab in Patients With Moderate-to-severe Osteoarthritis of the Hip or Knee.

Philip G Conaghan, Robert H Dworkin, Thomas J Schnitzer

|Aug 26, 2021
Validating a biosignature-predicting placebo pill response in chronic pain in the settings of a randomized controlled trial.

Etienne Vachon-Presseau, Taha B Abdullah, Sara E Berger

|Jul 19, 2021
Durability and delayed treatment effects of zoledronic acid on bone loss after spinal cord injury: a randomized, controlled trial.

W Brent Edwards, Ifaz T Haider, Narina Simonian

Pageof 2

Frequent Collaborators

2 joint publications

A Vania Apkarian

1 joint publications

Karen L Troy

1 joint publications

Megan E Mancuso

1 joint publications

Joshua E Johnson